Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials

Mantle cell lymphoma (MCL) is a mature B-cell neoplasm with a high initial response rate followed almost invariably by relapse. Here we report the pooled data from 2 studies, BGB-3111-AU-003 and BGB-3111-206, to explore the efficacy of zanubrutinib monotherapy in relapsed/refractory (R/R) MCL. A tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Keshu, Zou, Dehui, Zhou, Jianfeng, Hu, Jianda, Yang, Haiyan, Zhang, Huilai, Ji, Jie, Xu, Wei, Jin, Jie, Lv, Fangfang, Feng, Ru, Gao, Sujun, Zhou, Daobin, Tam, Constantine S., Simpson, David, Wang, Michael, Phillips, Tycel J., Opat, Stephen, Huang, Zhiyue, Lu, Huafei, Song, Yuqin, Song, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518153/
https://www.ncbi.nlm.nih.gov/pubmed/34649571
http://dx.doi.org/10.1186/s13045-021-01174-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518153/
https://www.ncbi.nlm.nih.gov/pubmed/34649571
http://dx.doi.org/10.1186/s13045-021-01174-3

Ejemplares similares